image
Foghorn Therapeutics Inc. FHTX
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 8.01
-8.98 %
$ 445 M
Market Cap
-4.77
P/E
FINANCIAL REPORTS

Reports

Report Date Revenue YoY Net Income YoY Operating Income YoY View
Annual Report FY 10-K 2023-12-31 77.63% 9.60% 7.88%
Annual Report FY 10-K 2022-12-31 1357.77% -5.47% -16.28%
Annual Report FY 10-K 2021-12-31 206.74% -47.93% -46.99%
Annual Report FY 10-K 2020-12-31 0.00% -35.05% -34.15%
Annual Report FY 10-K 2019-12-31 0.00% -96.18% -96.11%
Annual Report FY 10-K 2018-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2024-09-30 -55.33% -33.30% -39.64%
Quarterly Report Q2 8-K 2024-06-30 23.02% 22.07% 24.39%
Quarterly Report Q1 8-K 2024-03-31 -4.88% 17.95% 15.38%
Quarterly Report Q4 8-K 2023-12-31 37.88% 29.38% 20.16%
Quarterly Report Q3 8-K 2023-09-30 163.46% 38.38% 39.56%
Quarterly Report Q2 8-K 2023-06-30 24.70% -7.96% -9.81%
Quarterly Report Q1 8-K 2023-03-31 35.43% -17.15% -19.83%
Quarterly Report Q4 8-K 2022-12-31 486.82% -19.99% -13.55%
Quarterly Report Q3 8-K 2022-09-30 16080.49% 10.74% -7.61%
Quarterly Report Q2 8-K 2022-06-30 1509.32% -18.18% -25.48%
Quarterly Report Q1 8-K 2022-03-31 1270.63% -13.22% -20.21%
Quarterly Report Q4 8-K 2021-12-31 184.06% 248285.25% -35.15%
Quarterly Report Q3 8-K 2021-09-30 -77.09% -41.99% -42.04%
Quarterly Report Q2 8-K 2021-06-30 0.00% -46.99% -49.69%
Quarterly Report Q1 8-K 2021-03-31 0.00% -64.75% -68.54%
Quarterly Report Q4 8-K 2020-12-31 0.00% 99.55% -36.83%
Quarterly Report Q3 8-K 2020-09-30 0.00% -40.29% -41.14%
Quarterly Report Q2 8-K 2020-06-30 0.00% -38.26% -36.32%
Quarterly Report Q1 8-K 2020-03-31 0.00% -22.69% -20.40%
Quarterly Report Q4 8-K 2019-12-31 0.00% -132.25% -133.19%
Quarterly Report Q3 8-K 2019-09-30 0.00% -98.84% -101.16%
Quarterly Report Q2 8-K 2019-06-30 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2019-03-31 0.00% 0.00% 0.00%
Quarterly Report Q2 8-K 2018-06-30 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2018-03-31 0.00% 0.00% 0.00%